European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ).
Babjuk M, Burger M, Capoun O, Cohen D, Compérat EM, Dominguez Escrig JL, Gontero P, Liedberg F, Masson-Lecomte A, Mostafid AH, Palou J, van Rhijn BWG, Rouprêt M, Shariat SF, Seisen T, Soukup V, Sylvester RJ.
Eur Urol. 2022 Jan;81(1):75-94. doi: 10.1016/j.eururo.2021.08.010. Epub 2021 Sep 10.
Overview of current applications and trends in artificial intelligence for cystoscopy and transurethral resection of bladder tumours.
Ikeda A, Nosato H.
Curr Opin Urol. 2024 Jan 1;34(1):27-31. doi: 10.1097/MOU.0000000000001135. Epub 2023 Oct 30.
Bladder leiomyoma.
Mendes JE, Ferreira AV, Coelho SA, Gil C.
Urol Ann. 2017 Jul-Sep;9(3):275-277. doi: 10.4103/UA.UA_164_16.
Deep learning-based classification of blue light cystoscopy imaging during transurethral resection of bladder tumors.
Ali N, Bolenz C, Todenhöfer T, Stenzel A, Deetmar P, Kriegmair M, Knoll T, Porubsky S, Hartmann A, Popp J, Kriegmair MC, Bocklitz T.
Sci Rep. 2021 Jun 2;11(1):11629. doi: 10.1038/s41598-021-91081-x.
The Impact of Blue Light Cystoscopy on the Diagnosis and Treatment of Bladder Cancer.
Pietzak EJ.
Curr Urol Rep. 2017 May;18(5):39. doi: 10.1007/s11934-017-0685-8.
Multiparametric Cystoscopy for Detection of Bladder Cancer Using Real-time Multispectral Imaging.
Kriegmair MC, Rother J, Grychtol B, Theuring M, Ritter M, Günes C, Michel MS, Deliolanis NC, Bolenz C.
Eur Urol. 2020 Feb;77(2):251-259. doi: 10.1016/j.eururo.2019.08.024. Epub 2019 Sep 26.
Hexaminolevulinate blue light cystoscopy: a review of its use in the diagnosis of bladder cancer.
Yang LP.
Mol Diagn Ther. 2014 Feb;18(1):105-16. doi: 10.1007/s40291-013-0068-x.
Paraganglioma of the urinary bladder: a lesion that may be misdiagnosed as urothelial carcinoma in transurethral resection specimens.
Zhou M, Epstein JI, Young RH.
Am J Surg Pathol. 2004 Jan;28(1):94-100. doi: 10.1097/00000478-200401000-00011.
From macroscopic clearance to molecular eradication: paradigm shift and future perspectives in the detecting of residual lesions after transurethral resection of bladder tumors.
Zhang Y, Yan R, Wang H, Man J, Yang L.
Expert Rev Anticancer Ther. 2026 Apr;26(4):463-477. doi: 10.1080/14737140.2025.2597526. Epub 2025 Dec 2.
Improving the management of bladder cancer with fluorescence cystoscopy.
Grossman HB.
J Environ Pathol Toxicol Oncol. 2007;26(2):143-7. doi: 10.1615/jenvironpatholtoxicoloncol.v26.i2.90.
